The document outlines an investment fund's process to identify healthcare sectors for investment outside of drugs and vaccines. It describes: 1) Identifying 7 potential sectors and prioritizing them based on growth rate, diversification, and segment size. Clinical research organizations scored highest. 2) Developing a framework to screen companies based on performance, innovation, market potential, and management. 3) Recommending investment in clinical research organizations, healthcare IT, point-of-care diagnostics, and accountable care organizations. Three companies - Alpha, Beta, and Gamma - were identified as priorities based on growth rate, innovation, and financials.